Case number 1:23-cv-00410
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 17, 2023 | 8 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Inc. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) (Entered: 05/17/2023) (1) |
| May 17, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Ltd. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) (Entered: 05/17/2023) (1) |
| Apr 19, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 04/19/2023) (0) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Main Document) (13) |
| Apr 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 04/13/2023) (3) |
| Apr 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/16/23. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: Not Applicable. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) (Entered: 04/13/2023) (1) |
| Apr 13, 2023 | 7 | Summons Issued as to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on 4/13/2023. (Attachments: # 1 Summons Issued Dr. Reddy's Laboratories, Ltd.)(jfm) (Main Document 7 replaced on 4/14/2023) (jfm). (Attachment 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Main Document) (2) |
| Apr 13, 2023 | N/A | Remark: MDL panel has been advised. (jfm) (Entered: 04/14/2023) (0) |
| Apr 13, 2023 | 7 | Summons Issued as to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on 4/13/2023. (Attachments: # 1 Summons Issued Dr. Reddy's Laboratories, Ltd.)(jfm) (Main Document 7 replaced on 4/14/2023) (jfm). (Attachment 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Summons Issued Dr. Reddy's Laboratories, Ltd.) (2) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Exhibit A) (27) |
| Apr 13, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). (Entered: 04/13/2023) (Civil Cover Sheet) (2) |
